{"log_id": 507825745234377160, "direction": 0, "words_result_num": 51, "words_result": [{"probability": {"variance": 0, "average": 0.998246, "min": 0.998246}, "location": {"width": 27, "top": 112, "height": 27, "left": 1109}, "words": "督"}, {"probability": {"variance": 0.015292, "average": 0.938447, "min": 0.465351}, "location": {"width": 875, "top": 161, "height": 35, "left": 166}, "words": "用。在这方面,经过研究的药物主要是吗哚美。β受体阻滞剂很可能不与舒林酸发生相互作用。在"}, {"probability": {"variance": 0.009195, "average": 0.959119, "min": 0.567474}, "location": {"width": 585, "top": 195, "height": 27, "left": 164}, "words": "项双氢芬酸的研究中,未发现β受体阻滞剂与双氯芬酸有相互作用"}, {"probability": {"variance": 0.008857, "average": 0.960998, "min": 0.559272}, "location": {"width": 848, "top": 224, "height": 34, "left": 212}, "words": "苯海拉明:在快速羟化代谢人群中,苯海拉明使美托洛尔通过CYP2D6转化代谢成a-羟美托洛"}, {"probability": {"variance": 0.021198, "average": 0.931101, "min": 0.422492}, "location": {"width": 808, "top": 257, "height": 30, "left": 164}, "words": "的清除降低2.5倍。美托洛尔的作用因血增强苯海拉明可能排制其它CYP26底物的代谢"}, {"probability": {"variance": 0.019527, "average": 0.937286, "min": 0.45102}, "location": {"width": 849, "top": 287, "height": 33, "left": 211}, "words": "地尔硫卓:钙离子拮抗剂和β受体阻滞剂对于房室传导和窦房结功能有相加的抑制作用,已经有"}, {"probability": {"variance": 0.010989, "average": 0.957297, "min": 0.535539}, "location": {"width": 582, "top": 320, "height": 27, "left": 160}, "words": "β受体阻滞剂与地尔硫卓合并使用时发生明显心动过缓的病例报道"}, {"probability": {"variance": 0.011665, "average": 0.932399, "min": 0.558127}, "location": {"width": 851, "top": 351, "height": 32, "left": 210}, "words": "肾上腺素:约有10例报道显示,接受非选择性β受体阻滞剂(包括吲哚洛尔和普萘洛尔)治疗的"}, {"probability": {"variance": 0.006669, "average": 0.972191, "min": 0.498516}, "location": {"width": 894, "top": 382, "height": 32, "left": 164}, "words": "患者,在给予肾上腺素后发生明显的高血压和心动过缓。这些临床观察结果已经在对健康志愿者的研究"}, {"probability": {"variance": 0.015085, "average": 0.94457, "min": 0.467046}, "location": {"width": 897, "top": 415, "height": 28, "left": 163}, "words": "牛得到证实。局部麻醉药中的肾上腺素在血管内给药时有可能引起这种反应。根据推测,使用心班选择"}, {"probability": {"variance": 0.000517, "average": 0.98688, "min": 0.908871}, "location": {"width": 443, "top": 446, "height": 24, "left": 164}, "words": "性的β受体阻滞剂时,发生这种反应的危险性较低"}, {"probability": {"variance": 0.016431, "average": 0.92847, "min": 0.457038}, "location": {"width": 849, "top": 479, "height": 25, "left": 211}, "words": "苯丙醇胺:苯丙醇胺50m意单给药能便健康志愿者的舒张压升高到病理的水平。普洛尔通常"}, {"probability": {"variance": 0.011945, "average": 0.953767, "min": 0.40234}, "location": {"width": 897, "top": 508, "height": 29, "left": 162}, "words": "能抗这种由苯丙醇胺引起的血压增高。但是在接受大剂量苯丙醇胺治疗的患者中,β受体阴滞剂可反"}, {"probability": {"variance": 0.013674, "average": 0.952989, "min": 0.374415}, "location": {"width": 765, "top": 540, "height": 25, "left": 164}, "words": "常地引起高血压反应。在单独使用苯丙醇胺治疗的过程中,也有发生高压反应的报道"}, {"probability": {"variance": 0.017602, "average": 0.927823, "min": 0.493475}, "location": {"width": 851, "top": 570, "height": 29, "left": 210}, "words": "奎尼丁:奎尼丁在所谓的“快速羟化者(该类型在瑞典超过90%)中可抑制美托洛尔的代谢,结"}, {"probability": {"variance": 0.016737, "average": 0.935968, "min": 0.361215}, "location": {"width": 896, "top": 600, "height": 30, "left": 164}, "words": "果使后者的血浆浓度显著升高、β受体滞作用增强。其他经由同一解途径(细胞色素P450206)进"}, {"probability": {"variance": 0.018702, "average": 0.938761, "min": 0.463734}, "location": {"width": 568, "top": 633, "height": 24, "left": 162}, "words": "代谢的β受体灌剂,也可能会与美尼丁发生同样的相互作用"}, {"probability": {"variance": 0.011688, "average": 0.965348, "min": 0.363924}, "location": {"width": 852, "top": 661, "height": 29, "left": 209}, "words": "可乐定:β受体阻剂有可能加重可乐定突然停用时所发生的反跳性高血压。如欲终止与可乐定"}, {"probability": {"variance": 0.012764, "average": 0.955927, "min": 0.480597}, "location": {"width": 488, "top": 695, "height": 25, "left": 163}, "words": "的联治疗,应在停用可乐定前数日停用β受体阻滞剂"}, {"probability": {"variance": 0.010816, "average": 0.955731, "min": 0.461996}, "location": {"width": 585, "top": 725, "height": 27, "left": 211}, "words": "利福平:利福平可诱导美托洛尔的代谢,导致后者的血药浓度降低"}, {"probability": {"variance": 0.004515, "average": 0.964263, "min": 0.682997}, "location": {"width": 851, "top": 757, "height": 27, "left": 211}, "words": "应产密监控同时接受其它β受体阻滞剂(如:滴眼液)或单胺氧化酶(MAO)抑制剂的患者。在"}, {"probability": {"variance": 0.01572, "average": 0.941629, "min": 0.406181}, "location": {"width": 549, "top": 788, "height": 26, "left": 162}, "words": "接受β受体阻滞剂治疗的患者,吸入麻醉会增加心脏制作用"}, {"probability": {"variance": 0.008759, "average": 0.941899, "min": 0.616181}, "location": {"width": 850, "top": 819, "height": 26, "left": 211}, "words": "接受β受体阻滞剂治疗的患者应重新调整口服降糖药的剂量。若与西咪替丁肼屈嗪合用,美"}, {"probability": {"variance": 0.029948, "average": 0.894518, "min": 0.468004}, "location": {"width": 203, "top": 850, "height": 23, "left": 163}, "words": "洛尔的血浆浓度金增"}, {"probability": {"variance": 0.018566, "average": 0.930081, "min": 0.625791}, "location": {"width": 111, "top": 895, "height": 24, "left": 169}, "words": "【药物过量】"}, {"probability": {"variance": 0.020801, "average": 0.929378, "min": 0.437908}, "location": {"width": 852, "top": 927, "height": 26, "left": 211}, "words": "毒性:美托洛尔7.5引起成人致死性中毒。一例5岁儿童误服100mg经洗胃后无任何症状。12"}, {"probability": {"variance": 0.004829, "average": 0.964453, "min": 0.585383}, "location": {"width": 900, "top": 957, "height": 28, "left": 164}, "words": "岁儿童给予450mg引起中度中毒,成人给予1.4g引起中度中毒、给予2.5g引起重度中毒、给予7.5g"}, {"probability": {"variance": 0.007599, "average": 0.948122, "min": 0.739807}, "location": {"width": 142, "top": 990, "height": 23, "left": 164}, "words": "引起极重度中毒"}, {"probability": {"variance": 0.015836, "average": 0.9524, "min": 0.459535}, "location": {"width": 858, "top": 1020, "height": 26, "left": 205}, "words": "症状:心血管系统症状最为显著,但某些病例,特别是儿童和年轻患者,可能以中枢神经系统症状"}, {"probability": {"variance": 0.023438, "average": 0.921344, "min": 0.382869}, "location": {"width": 877, "top": 1052, "height": 25, "left": 165}, "words": "利呼吸抑制为主要表现,主要的中毒症状有心动过缓、11度房室传导阻滞、心搏停止、血压下降"}, {"probability": {"variance": 0.010699, "average": 0.944478, "min": 0.537699}, "location": {"width": 899, "top": 1082, "height": 24, "left": 164}, "words": "外周循环灌注不良、心功能不全、心源性体克、呼吸排制和室息。其他症状包括疲乏、精神错、神志"}, {"probability": {"variance": 0.020254, "average": 0.915709, "min": 0.450232}, "location": {"width": 897, "top": 1112, "height": 26, "left": 165}, "words": "丧失,频细震颤、痉挛、出汗、感觉异常、支气管痉挛、恶心、假吐、可能有食管痉挛、低糖(儿"}, {"probability": {"variance": 0.021069, "average": 0.911861, "min": 0.373165}, "location": {"width": 900, "top": 1143, "height": 25, "left": 162}, "words": "特别容易发生)或高血糖症、高钾症,对肾脏的影响,以及一过性肌无力综征。合并精:抗膏血"}, {"probability": {"variance": 0.006899, "average": 0.97069, "min": 0.552254}, "location": {"width": 898, "top": 1174, "height": 25, "left": 164}, "words": "压药、奎尼丁或巴比妥类药物可能加重患者的病情。药物过量的首发症状可见于服药后20分钟至2小"}, {"probability": {"variance": 0, "average": 0.999551, "min": 0.999551}, "location": {"width": 22, "top": 1208, "height": 22, "left": 164}, "words": "时"}, {"probability": {"variance": 0.014317, "average": 0.948112, "min": 0.475722}, "location": {"width": 850, "top": 1237, "height": 26, "left": 205}, "words": "治疗:诊断明确者,给予洗和活性炭,并严密观察病情变化,注意!为减少迷走神经刺激的危险"}, {"probability": {"variance": 0.017656, "average": 0.914452, "min": 0.478935}, "location": {"width": 899, "top": 1268, "height": 26, "left": 164}, "words": "洗胃前应先静脉给予阿托品(成人0.25-0.5mg,儿童10-20μgkg)。有指征时,进行气管内插管利"}, {"probability": {"variance": 0.012857, "average": 0.947299, "min": 0.44283}, "location": {"width": 897, "top": 1300, "height": 26, "left": 166}, "words": "支持治疗。给予适当的容量替代治疗,输注葡萄糖,监测心电图。阿托品1.0~2.0mg静脉注射,必要"}, {"probability": {"variance": 0.012227, "average": 0.927098, "min": 0.547885}, "location": {"width": 860, "top": 1331, "height": 25, "left": 166}, "words": "可重复注射(主要控制迷走神经症状)。对心肌功能抑制的患者,可滴注多巴丁胺或多巴胺,葡"}, {"probability": {"variance": 0.012008, "average": 0.922884, "min": 0.683032}, "location": {"width": 117, "top": 1362, "height": 22, "left": 166}, "words": "酸钙(mgm"}, {"probability": {"variance": 0.025153, "average": 0.685152, "min": 0.526556}, "location": {"width": 17, "top": 1365, "height": 17, "left": 343}, "words": "20"}, {"probability": {"variance": 0.020056, "average": 0.893659, "min": 0.488896}, "location": {"width": 720, "top": 1348, "height": 43, "left": 402}, "words": "另一种替代方法是胰高素50-150gkg1分钟内静脉注射,继人药有"}, {"probability": {"variance": 0.014181, "average": 0.941143, "min": 0.354542}, "location": {"width": 999, "top": 1361, "height": 65, "left": 164}, "words": "注,或用氨力农部分患者加用肾上腺素有效ORS波增宽和心律失的患者,可输注"}, {"probability": {"variance": 0.014576, "average": 0.939124, "min": 0.456925}, "location": {"width": 864, "top": 1421, "height": 32, "left": 165}, "words": "酸氢钠。可能需要安装心脏起搏器。对心搏骤停的患者,有时要长达数小时的复苏抢救。支"}, {"probability": {"variance": 0, "average": 0.985679, "min": 0.985679}, "location": {"width": 54, "top": 1408, "height": 56, "left": 1055}, "words": "★"}, {"probability": {"variance": 0.024287, "average": 0.91126, "min": 0.423904}, "location": {"width": 554, "top": 1453, "height": 23, "left": 167}, "words": "时,使用特布林(注射或费入)此外进行对症治"}, {"probability": {"variance": 1e-06, "average": 0.999208, "min": 0.997373}, "location": {"width": 161, "top": 1461, "height": 48, "left": 1003}, "words": "质量管理专用章"}, {"probability": {"variance": 0.002188, "average": 0.961258, "min": 0.872962}, "location": {"width": 109, "top": 1497, "height": 23, "left": 171}, "words": "【药理理】"}, {"probability": {"variance": 4e-06, "average": 0.99655, "min": 0.993603}, "location": {"width": 51, "top": 1507, "height": 26, "left": 1057}, "words": "(5)"}, {"probability": {"variance": 0.02144, "average": 0.905471, "min": 0.422372}, "location": {"width": 818, "top": 1526, "height": 29, "left": 207}, "words": "美托洛尔是一选择性的β1受体阻滞剂,其对心脏1受体产生作用所需剂量低于其对外置血"}, {"probability": {"variance": 0.035424, "average": 0.881395, "min": 0.555502}, "location": {"width": 104, "top": 1598, "height": 39, "left": 1058}, "words": "仪供存档"}], "language": 3}